BlackRock Group’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$448K Buy
558
+33
+6% +$26.5K ﹤0.01% 2387
2016
Q3
$444K Buy
525
+14
+3% +$11.8K ﹤0.01% 2335
2016
Q2
$422K Buy
511
+13
+3% +$10.7K ﹤0.01% 2318
2016
Q1
$554K Buy
498
+163
+49% +$181K ﹤0.01% 2189
2015
Q4
$418K Buy
335
+167
+99% +$208K ﹤0.01% 2261
2015
Q3
$227K Buy
168
+49
+41% +$66.2K ﹤0.01% 2483
2015
Q2
$214K Buy
119
+40
+51% +$71.9K ﹤0.01% 2543
2015
Q1
$128K Buy
+79
New +$128K ﹤0.01% 2595
2014
Q4
Sell
-30
Closed -$12K 2893
2014
Q3
$12K Buy
+30
New +$12K ﹤0.01% 2775